International thymic malignancy interest group

Journal of Thoracic Oncology

Volumn 5, Issue 1, 2010, Pages 1-2

  Detterbeck, Frank ^a   Giaccone, Giuseppe ^b   Loehrer, Patrick ^c   Suster, Saul ^d   Wright, Cameron ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; EDITORIAL; FUNDING; HEALTH CARE ORGANIZATION; INTERNATIONAL COOPERATION; LUNG CANCER; PRIORITY JOURNAL; THYMOMA; THYMUS CANCER;

EID: 76149139758     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181c59224     Document Type: Editorial

References (4)

1. Moran C, Suster S. Hematology/Oncology Clinics of North America, 3rd Ed. Philadelphia: Elsevier, 2008. Pp. 382-580.
2. Marchevsky AM, Gupta R, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only three categories other than thymic carcinoma. Cancer 2008;112:2780-2788.
3. Gupta R, Marchevsky AM, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 2008;132:926-930.
4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thymic Malignancies. V. 2.2009 Ed. PA: National Comprehensive Cancer Network, 2009.